BioSpace News Archive

There were multiple leadership changes in the biopharma industry, with several new chief executive officers tapped to guide companies through their next growth phases.

The Roche Accelerator is designed to help companies bridge the gap between idea and proof-of-concept. It is one of several incubators recently founded by Western companies.

Female scientists are now quantitatively not getting the credit they deserve, according to a new study published in the scientific journal Nature.

AbbVie has redeemed a Rare Pediatric Disease Priority Review Voucher for Rinvoq (upadactinib), following its FDA approval for adults with moderately to severely active ulcerative colitis in March.

Aadi Bioscience, Inc. announced it will join both the U.S. small cap Russell 2000® Index and broad-market Russell 3000® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective immediately after the U.S. market opens on June 24, 2022 according to a preliminary list of additions posted by FTSE Russell on June 3, 2022.

Pivotal Trial Expected to Enroll More Than 140 Patients With Moderate to Severe Congenital Ichthyosis at Leading Research Centers in the U.S., Canada, Italy, France, and Germany.

Health Canada approved Enhertu™ (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer who have received at least one prior anti-HER2-based regimen either in the metastatic setting, or in the neoadjuvant or adjuvant setting and developed disease recurrence during or within six months of completing neoadjuvant or adjuvant therapy.

Sid Taubenfeld with Extensive Experience in the Financial Markets and as a Biotech Executive Joins Tryp as Company Prepares to Expand Patient Access to Psilocybin-Based Treatments.

Dalrada Financial Corporation (OTCQB: DFCO , “Dalrada Financial Corporation”, “Dalrada”) today announced the appointment of Elizabeth Ann Winzeler, Ph.D., a Professor in the Department of Pediatrics at the University of California, San Diego, School of Medicine, as a member of the Dalrada Health advisory board.

Hummingbird Diagnostics GmbH, a leader in reading blood-based microRNAs for early disease detection and characterization, today announced a publication in the Journal of Thoracic Oncology Clinical and Research Reports.